These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38512690)

  • 1. Studying Microtubule Dynamics in Human Neurons: Two-Dimensional Microtubule Tracing and Kymographs in iPSC- and SH-SY5Y-Derived Neurons for Tau Research.
    Allroggen N; Breuer H; Bachmann S; Bell M; Zempel H
    Methods Mol Biol; 2024; 2754():561-580. PubMed ID: 38512690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Microtubule-Associated Protein Tau Mediates the Organization of Microtubules and Their Dynamic Exploration of Actin-Rich Lamellipodia and Filopodia of Cortical Growth Cones.
    Biswas S; Kalil K
    J Neurosci; 2018 Jan; 38(2):291-307. PubMed ID: 29167405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau isoform-specific stabilization of intermediate states during microtubule assembly and disassembly.
    Best RL; LaPointe NE; Liang J; Ruan K; Shade MF; Wilson L; Feinstein SC
    J Biol Chem; 2019 Aug; 294(33):12265-12280. PubMed ID: 31266806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating SH-SY5Y Cells into Polarized Human Neurons for Studying Endogenous and Exogenous Tau Trafficking: Four Protocols to Obtain Neurons with Noradrenergic, Dopaminergic, and Cholinergic Properties.
    Langerscheidt F; Bell-Simons M; Zempel H
    Methods Mol Biol; 2024; 2754():521-532. PubMed ID: 38512687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability.
    Bell M; Zempel H
    Rev Neurosci; 2022 Jan; 33(1):1-15. PubMed ID: 33866701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau and axonopathy in neurodegenerative disorders.
    Higuchi M; Lee VM; Trojanowski JQ
    Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitochondria cluster at the proximal axon initial segment controls axodendritic TAU trafficking in rodent primary and human iPSC-derived neurons.
    Tjiang N; Zempel H
    Cell Mol Life Sci; 2022 Feb; 79(2):120. PubMed ID: 35119496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics.
    Fontaine SN; Martin MD; Akoury E; Assimon VA; Borysov S; Nordhues BA; Sabbagh JJ; Cockman M; Gestwicki JE; Zweckstetter M; Dickey CA
    Hum Mol Genet; 2015 Jul; 24(14):3971-81. PubMed ID: 25882706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.
    Brandt R; Bakota L
    J Neurochem; 2017 Nov; 143(4):409-417. PubMed ID: 28267200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
    Mao CX; Wen X; Jin S; Zhang YQ
    Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies.
    Kovalevich J; Cornec AS; Yao Y; James M; Crowe A; Lee VM; Trojanowski JQ; Smith AB; Ballatore C; Brunden KR
    J Pharmacol Exp Ther; 2016 May; 357(2):432-50. PubMed ID: 26980057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
    Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
    Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal TAU Sorting Requires the C-terminus of TAU but is Independent of ANKG and TRIM46 Enrichment at the AIS.
    Bell M; Bachmann S; Klimek J; Langerscheidt F; Zempel H
    Neuroscience; 2021 May; 461():155-171. PubMed ID: 33556457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    Ivashko-Pachima Y; Maor-Nof M; Gozes I
    PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.